Skip to main content
Skin Research and Technology logoLink to Skin Research and Technology
letter
. 2022 Dec 19;29(1):e13237. doi: 10.1111/srt.13237

Double pass 595‐nm dye laser is not more effective than single pass: A systematic review and meta‐analysis

Lingling Yang 1, Xiaoyu Sun 1, Wenzhong Xiang 1,✉
PMCID: PMC9838754  PMID: 36537074

Dear Editor,

Port wine stain (PWS) is a congenital capillary malformation, affecting 0.3%–0.5% of the population. 1 It is characterized by a single pink and flat patch in infancy and may become thicken and darken during adults life, which significantly disturb the patients’ quality of life. Puled dye laser (PDL) has become the gold standard treatment of PWS. 2 , 3 However, there are only a minority of patients achieving total clearance of the PWS. 4 To improve the clearance rate of PWS, the concept of double‐pass pulsed‐dye laser (DPL) and single‐pass pulsed‐dye laser (SPL) were introduced. Nevertheless, compared to SPL, DPL has shown variable results. 5 , 6 , 7 , 8 , 9 , 10 The current position of DPL and SPL in the therapeutic scheme of PWS is lacking evidence‐based recommendations on efficacy and side effect. This meta‐analysis aims to compare the efficacy and tolerability of DPL versus SPL.

The study protocol was preregistered on PROSPERO (CRD42022299613). PUBMED, EMBASE, Web of Science and Cochrane library of randomized Controlled Trials were searched without any date restrictions. In addition, we searched the reference articles of eligibility studies reported. We excluded articles involving the use of dye laser combined with other laser equipment or topical drugs. Lingling Yang and Xiaoyu Sun independently extracted data from included studies. Four outcomes were used to compare the effect and safety: better clearance rate, visual improvement scale, blanching rate, and side effect rate. The meta‐analysis was performed with the Review Manager software (RevMan 5.3.5). We assessed the risk of bias of randomized controlled trials (RCTs) by The Risk of Bias Tool. Funnel plots were assessed to detect potential publication bias. We calculated I 2 statistics to examine the level of Heterogeneity. And, we did an additional sensitivity analysis with respect to trials included.

Six trials comprising 130 patients were included after full‐text screening. Study characters can be found in Table 1. The pooled analysis revealed no significant difference between DPL and SPL in blanching rate (MD = 0.04, 95% CI: −0.07 to 0.16, P = 0.46), better clearance rate (RR = 1.60, 95%CI:0.80 to 3.22, P = 0.19) and visual improvement (MD = 0.04, 95%CI:−0.28 to 0.36, p = 0.81). Furthermore, there was no difference in the side effect between two groups (RR = 1.17, 95% CI: 0.60 to 2.28, p = 0.65) (Figure 1). We used fixed‐effects model when the statistical heterogeneity was not important. The random‐effects model was used if the statistical heterogeneity was moderate. All of the pooled effects and side effects remain relatively stable in sensitivity analyses.

TABLE 1.

Characteristics of included studies

Author Year of publication (location) Participants characteristics Study design Intervention group (DPL) Control group (SPL) Treatment schedule Dropout rate Side effect
Noormohammad 2021 (Iran) 24 Double‐blind Randomized evaluator‐blinded control trial 7 mm, 20 ms, 13 J/cm2 +7 mm, 1.5 ms, 11 J/cm2 (at a 20‐min interval) 7 mm, 1.5 ms, 11 J/cm2

3 sessions

1 months interval

0%

DPL: 2 hyperpigmentation

SPL: 1 hyperpigmentation

Yu 2018 (China) 21

Randomized, single‐blinded, self‐control‐led comparative study

10 mm, 1.5 ms,10 J/cm2; 7 mm, 1.5 ms, 12 J/cm2+ 10 mm, 1.5 ms, 9 J/cm2; 7 mm, 1.5 ms, 11 J/cm2 (at a 30‐min interval) 10 mm, 1.5 ms, 10 J/cm2; 7 mm, 1.5 ms, 12 J/cm2

3 sessions

2 months interval

0%

DPL: 3 hyperpigmentation

SPL: 3 hyperpigmentation

Sajjad 2020 (Pakistan) 30 Single blind‐randomized controlled tria 7 mm, 2–6 ms, 8‐12 J/cm2 +7 mm, 2‐6 ms, 4‐6 J/cm2 (at a 30‐min interval) 7 mm,2‐6 ms, 8–12 J/cm2

4 sessions

3 weeks interval

0% No side effect
Peter 2012 (Netherlands) 17 Randomized evaluator‐blinded trial 7 mm, 1.5 ms 11 J/cm2 × 2 (at a 6‐min interval)

7 mm,1.5 ms

12 J/cm2

2 sessions

6–10 weeks interval

5.9%(1) (personal reasons)

DPL: 4 hyperpigmentation

2 hypopigmentation

1 scar

SPL: 4 hyperpigmentation

2 hypopigmentation

David 2008 (Britain) 18 Randomized Controlled trial 7 mm, 0.45 ms, 7 J/cm2 × 2 (at a 30‐s interval) 7 mm, 0.45 ms, 7 J/cm2 1 session 11.1% (2) (personal reasons) No side effect
Brauer 2017 America 20 single‐center, randomized, Controlled, split‐lesion pilot study

10 mm, 0.45–1.5 ms

6–9 J/cm2+

10 mm, 6 ms

7.5 J/cm2 (at a 2‐day interval)

10 mm, 0.45–1.5 ms

6–9 J/cm2

2 sessions

4–8 weeks interval

0%

DPL: 1 Hypopigmentation

1 hyperpigmentation

SPL: 1 Hypopigmentation

1 hyperpigmentation

FIGURE 1.

FIGURE 1

Forest plot revealed that there were no significant difference between double‐pass pulsed‐dye laser (DPL) and single‐pass pulsed‐dye laser (SPL) in better clearance rate (A), visual improvement (B), blanching rate (C), and side effect (D).

The current evidence demonstrated that DPL had similar efficacy and side effects with SPL. There are multiple possible reasons for the similar results. First, skin lesion depth of PWS ranges from 1 to 5 mm. 11 But, PDL had limited ability to affect vessels residing deeper than 2 mm in the skin 12 , 13 Double pass depth of vascular injury was 2.78 ± 0.9 mm for inter‐pulse interval of 30 min, which was significantly greater than SPL (0.9 ± 0.2 mm), 14 but this therapy was conducted on normal skin, not PWS lesions. Another trail's results indicated photothermal damage of a similar depth after SPL and DPL therapies, with mildly greater vessel wall damage on the DPL‐treated sides. 7 Therefore, whether the depth of vascular injury in DPL increases is unknown. Second, Previous studies had shown that angiogenesis pathways (specifically vascular endothelial growth factor and hypoxia inducible factor‐1α) were activated during the wound healing process. 15 , 16 , 17 Compared to SPL, the more serious injury of DPL may lead to more postlaser revascularizations, indicating the limited effect of PDL.

This study had a few limitations. First, three randomized studies had a high risk of bias; two randomized trails had a moderate risk of bias. However, our analysis included only prospective, controlled studies to capture the evidence available. Second, the total number of studies and patients with PWS was low. Nonetheless, all the included trails were RCTs.

In conclusion, at present, PWS cannot be cured completely, although PDL was considered as the gold standard treatment. This combined systematic review demonstrated that the effectiveness of DPL was comparable to SPL.

CONFLICT OF INTEREST

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Yang L, Sun X, Xiang W. Double pass 595‐nm dye laser is not more effective than single pass: A systematic review and meta‐analysis. Skin Res Technol. 2023;29:1–4. 10.1111/srt.13237

DATA AVAILABILITY STATEMENT

Research data are not shared.

REFERENCES

  • 1. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics. 1976;58(2):218‐222. [PubMed] [Google Scholar]
  • 2. Lanigan SW, Taibjee SM. Recent advances in laser treatment of port‐wine stains. Br J Dermatol. 2004;151(3):527‐533. [DOI] [PubMed] [Google Scholar]
  • 3. Faurschou A, Olesen AB, Leonardi‐Bee J, Haedersdal M. Lasers or light sources for treating port‐wine stains. Cochrane Database Syst Rev. 2011(11):Cd007152. 10.1002/14651858.CD007152.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Rajaratnam R, Laughlin SA, Dudley D. Pulsed dye laser double‐pass treatment of patients with resistant capillary malformations. Lasers Med Sci. 2011;26(4):487‐492. [DOI] [PubMed] [Google Scholar]
  • 5. McGill DJ, MacLaren W, Mackay IR. A direct comparison of pulsed dye, alexandrite, KTP and Nd: YAG lasers and IPL in patients with previously treated Capillary Malformations. Lasers Surg Med. 2008;40(6):390‐398. [DOI] [PubMed] [Google Scholar]
  • 6. Noormohammadpour P, Ehsani AH, Mahmoudi H, Balighi K, Razavi Z. Does double‐pass pulsed‐dye laser with long and short pulse duration increase treatment efficacy of port‐wine stain? A Randomized Clinical Trial. Dermatol Surg. 2021;47(4):e122‐e126. [DOI] [PubMed] [Google Scholar]
  • 7. Yu W, Zhu J, Wang L, et al. Double pass 595 nm pulsed dye laser does not enhance the efficacy of port wine stains compared with single pass: a randomized comparison with histological examination. Photomed Laser Surg. 2018;36(6):305‐312. [DOI] [PubMed] [Google Scholar]
  • 8. Sajjad Y, Haider MF, Rahat B, Afzal MO, Iqbal MT. Single and double pass pulsed dye laser for the treatment of port wine stain: a randomized controlled trial. Ann King Edward Med Univ Lahore Pakistan. 2020;26(1):67‐71. [Google Scholar]
  • 9. Peters MA, van Drooge AM, Wolkerstorfer A, et al. Double pass 595 nm pulsed dye laser at a 6 minute interval for the treatment of port‐wine stains is not more effective than single pass. Lasers Surg Med.2012;44(3):199‐204. [DOI] [PubMed] [Google Scholar]
  • 10. Brauer JA, Farhadian JA, Bernstein LJ, Bae YS, Geronemus RG. Pulsed dye laser at subpurpuric settings for the treatment of pulsed dye laser‐induced ecchymoses in patients with port‐wine stains. Dermatol Surg. 2018;44 (2):220‐226. [DOI] [PubMed] [Google Scholar]
  • 11. Izikson L, Anderson RR. Treatment endpoints for resistant port wine stains with a 755 nm laser. J Cosmet Laser Ther. 2009;11(1):52‐55. [DOI] [PubMed] [Google Scholar]
  • 12. Garden JM. Laser removal of port wine stains: how close are we? A Commentary. Lasers Surg Med. 2007;39(7):569‐570. [DOI] [PubMed] [Google Scholar]
  • 13. Jasim ZF, Handley JM. Treatment of pulsed dye laser‐resistant port wine stain birthmarks. J Am Acad Dermatol. 2007;57(4):677‐682. [DOI] [PubMed] [Google Scholar]
  • 14. Tanghetti E, Sherr EA, Sierra R, Mirkov M. The effects of pulse dye laser double‐pass treatment intervals on depth of vessel coagulation. Lasers Surg Med. 2006;38(1):16‐21. [DOI] [PubMed] [Google Scholar]
  • 15. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220(4596):524‐527. [DOI] [PubMed] [Google Scholar]
  • 16. Guba M, von Breitenbuch P, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med. 2002;8(2):128‐135. [DOI] [PubMed] [Google Scholar]
  • 17. Marqués L, Núñez‐Córdoba JM, Aguado L, et al. Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge‐Weber syndrome: phase II, randomized, double‐blind, intraindividual placebo‐controlled clinical trial. J Am Acad Dermatol. 2015;72(1):151‐158.e1. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Research data are not shared.


Articles from Skin Research and Technology are provided here courtesy of International Society of Biophysics and Imaging of the Skin, International Society for Digital Imaging of the Skin, and John Wiley & Sons Ltd

RESOURCES